GREENWICH, Conn., Dec. 10, 2020 /PRNewswire/ -- Sarissa
Capital Acquisition Corp. (the "Company") announced today that,
commencing December 11, 2020, holders
of the 20,000,000 units sold in the Company's initial public
offering may elect to separately trade the Company's Class A
ordinary shares and warrants included in the units. Class A
ordinary shares and warrants that are separated will trade on The
Nasdaq Capital Market under the symbols "SRSA" and "SRSAW,"
respectively. No fractional warrants will be issued upon separation
of the units and only whole warrants will trade. Those units not
separated will continue to trade on The Nasdaq Capital Market under
the symbol "SRSAU." Holders of units will need to have their
brokers contact Continental Stock Transfer & Trust Company, the
Company's transfer agent, in order to separate the units into Class
A ordinary shares and warrants.
The Company is a new blank check company incorporated for the
purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with
one or more businesses. While the Company may pursue an acquisition
opportunity in any industry or sector, it intends to focus on the
healthcare industry in the United
States and other developed countries.
The units were initially offered by the Company in an
underwritten offering. Cantor Fitzgerald & Co. acted as the
sole book-running manager for the offering. A registration
statement relating to these securities was declared effective by
the Securities and Exchange Commission ("SEC") on October 20, 2020. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
Cautionary Note Concerning Forward-Looking
Statements
This press release contains statements that constitute
"forward-looking statements," including with respect to the initial
public offering, the anticipated use of the net proceeds and search
for an initial business combination. No assurance can be given that
the offering discussed above will be completed on the terms
described, or at all, or that the net proceeds of the offering will
be used as indicated. Forward-looking statements are subject to
numerous conditions, many of which are beyond the control of the
Company, including those set forth in the "Risk factors" section of
the Company's registration statement and prospectus for the
Company's offering filed with the SEC. Copies are available on the
SEC's website, www.sec.gov. The Company undertakes no obligation to
update these statements for revisions or changes after the date of
this release, except as required by law.
About Sarissa Capital Acquisition Corp.
Sarissa Capital Acquisition Corp. (the "Company") is a new blank
check company incorporated for the purpose of effecting a merger,
share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses. The
Company's sponsor, Sarissa Capital Acquisition Sponsor LLC, was
capitalized by investment funds managed by Sarissa Capital
Management LP, which was founded by Alex Denner, Ph.D. While the Company may pursue
an acquisition opportunity in any industry or sector, it intends to
focus on the healthcare industry in the
United States and other developed countries.
Contact
Eric
Vincent
Sarissa Capital Acquisition Corp.
203-302-2460
Media Contacts:
Steve
Bruce / Taylor Ingraham
ASC Advisors
203-992-1230
sbruce@ascadvisors.com / tingraham@ascadvisors.com
View original
content:http://www.prnewswire.com/news-releases/sarissa-capital-acquisition-corp-announces-the-separate-trading-of-its-class-a-ordinary-shares-and-warrants-301190831.html
SOURCE Sarissa Capital Acquisition Corp.